VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 69 filers reported holding VERVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,978 | -29.3% | 300,000 | 0.0% | 0.17% | -1.7% |
| Q2 2023 | $5,625 | +30.0% | 300,000 | 0.0% | 0.17% | -32.3% |
| Q1 2023 | $4,326 | -25.5% | 300,000 | 0.0% | 0.26% | -20.7% |
| Q4 2022 | $5,805 | -100.0% | 300,000 | -25.0% | 0.32% | -44.7% |
| Q3 2022 | $13,740,000 | +124.8% | 400,000 | 0.0% | 0.59% | +79.8% |
| Q2 2022 | $6,112,000 | -33.0% | 400,000 | 0.0% | 0.33% | -14.7% |
| Q1 2022 | $9,128,000 | -38.1% | 400,000 | 0.0% | 0.38% | -4.5% |
| Q4 2021 | $14,748,000 | -21.6% | 400,000 | 0.0% | 0.40% | -5.0% |
| Q3 2021 | $18,800,000 | -37.6% | 400,000 | -20.0% | 0.42% | -31.1% |
| Q2 2021 | $30,125,000 | – | 500,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |